Author: Hardeep Singh Tuli
Publisher: Frontiers Media SA
ISBN: 2832504507
Category : Science
Languages : en
Pages : 168
Book Description
Current Aspects in Chemopreventive Strategies, Volume II
Author: Hardeep Singh Tuli
Publisher: Frontiers Media SA
ISBN: 2832504507
Category : Science
Languages : en
Pages : 168
Book Description
Publisher: Frontiers Media SA
ISBN: 2832504507
Category : Science
Languages : en
Pages : 168
Book Description
Editorial: Current Aspects in Chemopreventive Strategies
Author: Hardeep Singh Tuli
Publisher: Frontiers Media SA
ISBN: 2889664627
Category : Science
Languages : en
Pages : 133
Book Description
Publisher: Frontiers Media SA
ISBN: 2889664627
Category : Science
Languages : en
Pages : 133
Book Description
Herbal Medicine Phytochemistry
Author: Sylvester Chibueze Izah
Publisher: Springer Nature
ISBN: 3031431995
Category :
Languages : en
Pages : 2211
Book Description
Publisher: Springer Nature
ISBN: 3031431995
Category :
Languages : en
Pages : 2211
Book Description
COVID-19: New Variants and Host Demography
Author: Ginpreet Kaur
Publisher: Frontiers Media SA
ISBN: 2889762289
Category : Science
Languages : en
Pages : 214
Book Description
Publisher: Frontiers Media SA
ISBN: 2889762289
Category : Science
Languages : en
Pages : 214
Book Description
Cancer Chemoprevention
Author: Gary J. Kelloff
Publisher: Springer Science & Business Media
ISBN: 1592597688
Category : Medical
Languages : en
Pages : 537
Book Description
Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy. cancer survival has remained relatively flat over the past All these biomarkers have the potential to greatly augment several decades (1,2). However, new technology the development of successful chemoprevention therapies, allowing exploration of signal transduction pathways, but two specific types of biomarkers will have the most identification of cancer-associated genes, and imaging of immediate impact on successful chemopreventive drug tissue architecture and molecular and cellular function is development—those that measure the risk of developing increasing our understanding of carcinogenesis and cancer invasive life-threatening disease, and those whose mo- progression. This knowledge is moving the focus of cancer lation can “reasonably predict” clinical benefit and, therapeutics, including cancer preventive treatments, to therefore, serve as surrogate endpoints for later-occurring drugs that take advantage of cellular control mechanisms clinical disease. Thus far, the biomarker that best measures to selectively suppress cancer progression. these two phenomena is intraepithelial neoplasia (IEN) Carcinogenesis is now visualized as a multifocal, because it is a near obligate precursor to cancer.
Publisher: Springer Science & Business Media
ISBN: 1592597688
Category : Medical
Languages : en
Pages : 537
Book Description
Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy. cancer survival has remained relatively flat over the past All these biomarkers have the potential to greatly augment several decades (1,2). However, new technology the development of successful chemoprevention therapies, allowing exploration of signal transduction pathways, but two specific types of biomarkers will have the most identification of cancer-associated genes, and imaging of immediate impact on successful chemopreventive drug tissue architecture and molecular and cellular function is development—those that measure the risk of developing increasing our understanding of carcinogenesis and cancer invasive life-threatening disease, and those whose mo- progression. This knowledge is moving the focus of cancer lation can “reasonably predict” clinical benefit and, therapeutics, including cancer preventive treatments, to therefore, serve as surrogate endpoints for later-occurring drugs that take advantage of cellular control mechanisms clinical disease. Thus far, the biomarker that best measures to selectively suppress cancer progression. these two phenomena is intraepithelial neoplasia (IEN) Carcinogenesis is now visualized as a multifocal, because it is a near obligate precursor to cancer.
Plant Biotechnology, Volume 2
Author: Sangita Sahni
Publisher: CRC Press
ISBN: 135181947X
Category : Science
Languages : en
Pages : 356
Book Description
This volume is the second of the new two-volume Plant Biotechnology set. This volume covers many recent advances in the development of transgenic plants that have revolutionized our concepts of sustainable food production, cost-effective alternative energy strategies, microbial biofertilizers and biopesticides, and disease diagnostics through plant biotechnology. With the advancements in plant biotechnology, many of the customary approaches are out of date, and an understanding of new updated approaches is needed. This volume presents information related to recent methods of genetic transformation, gene silencing, development of transgenic crops, biosafety issues, microbial biotechnology, oxidative stress, and plant disease diagnostics and management. Key features: Provides an in-depth knowledge of various techniques of genetic transformation of plants, chloroplast, and fungus Describes advances in gene silencing in plants Discusses transgenic plants for various traits and their application in crop improvement Looks at genetically modified foods and biodiesel production Describes biotechnological approaches in horticultural and ornamental plants Explores the biosafety aspect associated with transgenic crops Considers the role of microbes in sustainable agriculture
Publisher: CRC Press
ISBN: 135181947X
Category : Science
Languages : en
Pages : 356
Book Description
This volume is the second of the new two-volume Plant Biotechnology set. This volume covers many recent advances in the development of transgenic plants that have revolutionized our concepts of sustainable food production, cost-effective alternative energy strategies, microbial biofertilizers and biopesticides, and disease diagnostics through plant biotechnology. With the advancements in plant biotechnology, many of the customary approaches are out of date, and an understanding of new updated approaches is needed. This volume presents information related to recent methods of genetic transformation, gene silencing, development of transgenic crops, biosafety issues, microbial biotechnology, oxidative stress, and plant disease diagnostics and management. Key features: Provides an in-depth knowledge of various techniques of genetic transformation of plants, chloroplast, and fungus Describes advances in gene silencing in plants Discusses transgenic plants for various traits and their application in crop improvement Looks at genetically modified foods and biodiesel production Describes biotechnological approaches in horticultural and ornamental plants Explores the biosafety aspect associated with transgenic crops Considers the role of microbes in sustainable agriculture
Cancer Chemoprevention
Author: Raymond C. Bergan
Publisher: Springer
ISBN: 9781461356639
Category : Medical
Languages : en
Pages : 0
Book Description
This volume offers a broad overview of topics related to cancer chemoprevention. It provides a review of topics ranging from basic research arenas to clinical trial design, implementation, and interpretation. It covers all key areas necessary for understanding the field of cancer chemoprevention for the interested reader, for individuals wishing to enter this area of investigation, and for individuals seeking guidance in particular areas of research, relating to agent identification, basic science investigations and clinical trials. The genesis of this book is based on the fact that cancer chemoprevention is a relatively new and rapidly evolving field spanning a wide array of disciplines, and forces researchers to address difficult and complex questions whose answers are not readily available. Cancer Chemoprevention provides a ready resource whose importance and intent lie in its ability to gather and solidify disparate data to explicitly outline areas of difficulty and to highlight future areas of important development. It provides broad outlines for current, ongoing and future directions in this area with various target organ sites, written by experts in their respective fields, whose primary research focuses upon that individual field.
Publisher: Springer
ISBN: 9781461356639
Category : Medical
Languages : en
Pages : 0
Book Description
This volume offers a broad overview of topics related to cancer chemoprevention. It provides a review of topics ranging from basic research arenas to clinical trial design, implementation, and interpretation. It covers all key areas necessary for understanding the field of cancer chemoprevention for the interested reader, for individuals wishing to enter this area of investigation, and for individuals seeking guidance in particular areas of research, relating to agent identification, basic science investigations and clinical trials. The genesis of this book is based on the fact that cancer chemoprevention is a relatively new and rapidly evolving field spanning a wide array of disciplines, and forces researchers to address difficult and complex questions whose answers are not readily available. Cancer Chemoprevention provides a ready resource whose importance and intent lie in its ability to gather and solidify disparate data to explicitly outline areas of difficulty and to highlight future areas of important development. It provides broad outlines for current, ongoing and future directions in this area with various target organ sites, written by experts in their respective fields, whose primary research focuses upon that individual field.
Journal of the National Cancer Institute
Author:
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 988
Book Description
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 988
Book Description
Chemoprevention of Cancer
Author: Daniel W. Nixon
Publisher: CRC Press
ISBN: 9780849368509
Category : Medical
Languages : en
Pages : 160
Book Description
Chemoprevention of Cancer guides you through the exciting new field of cancer chemoprevention. It covers epidemiology, known chemopreventive compounds, development of new chemopreventive agents, specific examples of preventive agents and their mechanisms of action, and current prevention clinical trials.
Publisher: CRC Press
ISBN: 9780849368509
Category : Medical
Languages : en
Pages : 160
Book Description
Chemoprevention of Cancer guides you through the exciting new field of cancer chemoprevention. It covers epidemiology, known chemopreventive compounds, development of new chemopreventive agents, specific examples of preventive agents and their mechanisms of action, and current prevention clinical trials.
Familial Breast and Ovarian Cancer
Author: Patrick J. Morrison
Publisher: Cambridge University Press
ISBN: 1139437720
Category : Medical
Languages : en
Pages : 419
Book Description
This publication surveys the profound and far-reaching ramifications that have arisen from the very significant advances in our understanding of the genetic basis of familial breast and ovarian cancer. Written by international experts from Europe and North America, this book provides the busy clinician with a contemporary and wide-ranging guide to the latest developments in the diagnosis, genetics, screening, prevention and management of familial breast cancer. This area has advanced in knowledge so rapidly that this publication provides an unrivalled source of information including sections on ethical and insurance issues and the different cultural differences in breast cancer. The use of recently devised cancer genetics clinics and different referral criteria and patterns to these clinics are detailed. The volume will be of immense value to all clinical geneticists, oncologists, and healthcare professionals involved in screening and counselling programmes.
Publisher: Cambridge University Press
ISBN: 1139437720
Category : Medical
Languages : en
Pages : 419
Book Description
This publication surveys the profound and far-reaching ramifications that have arisen from the very significant advances in our understanding of the genetic basis of familial breast and ovarian cancer. Written by international experts from Europe and North America, this book provides the busy clinician with a contemporary and wide-ranging guide to the latest developments in the diagnosis, genetics, screening, prevention and management of familial breast cancer. This area has advanced in knowledge so rapidly that this publication provides an unrivalled source of information including sections on ethical and insurance issues and the different cultural differences in breast cancer. The use of recently devised cancer genetics clinics and different referral criteria and patterns to these clinics are detailed. The volume will be of immense value to all clinical geneticists, oncologists, and healthcare professionals involved in screening and counselling programmes.